- Home
- GEVO vs ZVRA Comparison
GEVO vs ZVRA Comparison
Compare GEVO & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ZVRA
- Stock Information
- Founded
- GEVO 2005
- ZVRA 2006
- Country
- GEVO United States
- ZVRA United States
- Employees
- GEVO N/A
- ZVRA N/A
- Industry
- GEVO Major Chemicals
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- ZVRA Health Care
- Exchange
- GEVO Nasdaq
- ZVRA Nasdaq
- Market Cap
- GEVO 498.2M
- ZVRA 467.6M
- IPO Year
- GEVO 2011
- ZVRA 2015
- Fundamental
- Price
- GEVO $2.21
- ZVRA $10.99
- Analyst Decision
- GEVO Buy
- ZVRA Strong Buy
- Analyst Count
- GEVO 2
- ZVRA 8
- Target Price
- GEVO $8.13
- ZVRA $22.57
- AVG Volume (30 Days)
- GEVO 6.9M
- ZVRA 2.7M
- Earning Date
- GEVO 11-06-2025
- ZVRA 11-11-2025
- Dividend Yield
- GEVO N/A
- ZVRA N/A
- EPS Growth
- GEVO N/A
- ZVRA N/A
- EPS
- GEVO N/A
- ZVRA N/A
- Revenue
- GEVO $80,187,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- GEVO $909.99
- ZVRA $336.43
- Revenue Next Year
- GEVO $22.37
- ZVRA $54.26
- P/E Ratio
- GEVO N/A
- ZVRA N/A
- Revenue Growth
- GEVO 341.75
- ZVRA 161.81
- 52 Week Low
- GEVO $0.92
- ZVRA $6.19
- 52 Week High
- GEVO $3.39
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- GEVO 64.72
- ZVRA 65.90
- Support Level
- GEVO $2.14
- ZVRA $9.08
- Resistance Level
- GEVO $2.37
- ZVRA $11.23
- Average True Range (ATR)
- GEVO 0.13
- ZVRA 0.67
- MACD
- GEVO 0.01
- ZVRA 0.27
- Stochastic Oscillator
- GEVO 65.56
- ZVRA 92.23
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.